Neophytou P I, Roep B O, Arden S D, Muir E M, Duinkerken G, Kallan A, de Vries R R, Hutton J C
Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, United Kingdom.
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2014-8. doi: 10.1073/pnas.93.5.2014.
Studies on circulating T cells and antibodies in newly diagnosed type 1 diabetic patients and rodent models of autoimmune diabetes suggest that beta-cell membrane proteins of 38 kDa may be important molecular targets of autoimmune attack. Biochemical approaches to the isolation and identification of the 38-kDa autoantigen have been hampered by the restricted availability of islet tissue and the low abundance of the protein. A procedure of epitope analysis for CD4+ T cells using subtracted expression libraries (TEASEL) was developed and used to clone a 70-amino acid pancreatic beta-cell peptide incorporating an epitope recognized by a 38-kDa-reactive CD4+ T-cell clone (1C6) isolated from a human diabetic patient. The minimal epitope was mapped to a 10-amino acid synthetic peptide containing a DR1 consensus binding motif. Data base searches did not reveal the identity of the protein, though a weak homology to the bacterial superantigens SEA (Streptococcus pyogenes exotoxin A) and SEB (Staphylococcus aureus enterotoxin B) (23% identity) was evident. The TEASEL procedure might be used to identify epitopes of other autoantigens recognized by CD4+ T cells in diabetes as well as be more generally applicable to the study low-abundance autoantigens in other tissue-specific autoimmune diseases.
对新诊断的1型糖尿病患者及自身免疫性糖尿病啮齿动物模型中循环T细胞和抗体的研究表明,38 kDa的β细胞膜蛋白可能是自身免疫攻击的重要分子靶点。由于胰岛组织获取受限以及该蛋白丰度较低,用于分离和鉴定38 kDa自身抗原的生化方法受到了阻碍。开发了一种使用消减表达文库对CD4+ T细胞进行表位分析的方法(TEASEL),并用于克隆一种70个氨基酸的胰腺β细胞肽,该肽包含从一名人类糖尿病患者分离出的与38 kDa反应性CD4+ T细胞克隆(1C6)识别的表位。最小表位被定位到一个含有DR1共有结合基序的10个氨基酸的合成肽上。数据库搜索未揭示该蛋白的身份,不过与细菌超抗原SEA(化脓性链球菌外毒素A)和SEB(金黄色葡萄球菌肠毒素B)有微弱同源性(23%的同一性)是明显的。TEASEL方法可用于鉴定糖尿病中CD4+ T细胞识别的其他自身抗原的表位,也更普遍适用于研究其他组织特异性自身免疫疾病中的低丰度自身抗原。